News Releases

Date	Title	Additional Formats
May 25, 2021	Phathom Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
May 11, 2021	Phathom Pharmaceuticals Reports First Quarter 2021 Results and Provides Recent Business Updates
May 6, 2021	Phathom Pharmaceuticals to Present at the Bank of America Securities 2021 Virtual Healthcare Conference
April 29, 2021	Phathom Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Trial of Vonoprazan in Helicobacter pylori (H. pylori) Infection; Study Met All Primary and Secondary Endpoints
April 6, 2021	Phathom Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference
March 30, 2021	Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress
January 19, 2021	Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Helicobacter pylori (H. pylori) Trial